Search

Author/Creator Tien, Kai-Jen

1. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Issue 10184 (11th May 2019)

Authors:
Heerspink, Hiddo J L; Parving, Hans-Henrik; Andress, Dennis L; Bakris, George; Correa-Rotter, Ricardo; Hou, Fan-Fan; Kitzman, Dalane W; Kohan, Donald; Makino, Hirofumi; McMurray, John J V; Melnick, Joel Z; Miller, Michael G; Pergola, Pablo E; Perkovic, Vlado; Tobe, Sheldon; Yi, Tingting; Wigderso...
Journal:
Lancet
Issue:
Volume 393:Issue 10184(2019)
Page Start:
1937
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial. Issue 10313 (13th November 2021)

Authors:
Del Prato, Stefano; Kahn, Steven E; Pavo, Imre; Weerakkody, Govinda J; Yang, Zhengyu; Doupis, John; Aizenberg, Diego; Wynne, Alan G; Riesmeyer, Jeffrey S; Heine, Robert J; Wiese, Russell J; Ahmann, Andrew J; Arora, Samir; Ball, Eric M; Calderon, Rafael B; Butuk, David J; Chaychi, Leila; Chen, Mic...
Journal:
Lancet
Issue:
Volume 398:Issue 10313(2021)
Page Start:
1811
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗